305 related articles for article (PubMed ID: 22061491)
1. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.
Cheng D; Cao N; Chen J; Yu X; Shuai X
Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491
[TBL] [Abstract][Full Text] [Related]
2. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
[TBL] [Abstract][Full Text] [Related]
4. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
6. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
Peng Y; Huang J; Xiao H; Wu T; Shuai X
Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy.
Chen W; Yuan Y; Cheng D; Chen J; Wang L; Shuai X
Small; 2014 Jul; 10(13):2678-87. PubMed ID: 24668891
[TBL] [Abstract][Full Text] [Related]
8. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro.
Shamshiripour P; Rahnama M; Nikoobakht M; Rad VF; Moradi AR; Ahmadvand D
J Control Release; 2024 May; 369():128-145. PubMed ID: 38522817
[TBL] [Abstract][Full Text] [Related]
12. Gene and doxorubicin co-delivery system for targeting therapy of glioma.
Liu S; Guo Y; Huang R; Li J; Huang S; Kuang Y; Han L; Jiang C
Biomaterials; 2012 Jun; 33(19):4907-16. PubMed ID: 22484049
[TBL] [Abstract][Full Text] [Related]
13. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
[TBL] [Abstract][Full Text] [Related]
15. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
16. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer.
Han L; Huang R; Li J; Liu S; Huang S; Jiang C
Biomaterials; 2011 Feb; 32(4):1242-52. PubMed ID: 20971503
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
18. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X
Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
Maeng JH; Lee DH; Jung KH; Bae YH; Park IS; Jeong S; Jeon YS; Shim CK; Kim W; Kim J; Lee J; Lee YM; Kim JH; Kim WH; Hong SS
Biomaterials; 2010 Jun; 31(18):4995-5006. PubMed ID: 20347138
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
